Your browser doesn't support javascript.
loading
The imidazodiazepine, KRM-II-81: An example of a newly emerging generation of GABAkines for neurological and psychiatric disorders.
Witkin, Jeffrey M; Lippa, Arnold; Smith, Jodi L; Jin, Xiaoming; Ping, Xingjie; Biggerstaff, Andrew; Kivell, Bronwyn M; Knutson, Daniel E; Sharmin, Dishary; Pandey, Kamal P; Mian, Md Yeunus; Cook, James M; Cerne, Rok.
Afiliação
  • Witkin JM; Laboratory of Antiepileptic Drug Discovery, Ascension St. Vincent, Indianapolis, IN, USA; RespireRx Pharmaceuticals Inc., Glen Rock, NJ, USA; Department of Chemistry and Biochemistry, Milwaukee Institute of Drug Discovery, University of Wisconsin-Milwaukee, Milwaukee, WI, USA. Electronic address: wi
  • Lippa A; RespireRx Pharmaceuticals Inc., Glen Rock, NJ, USA.
  • Smith JL; Laboratory of Antiepileptic Drug Discovery, Ascension St. Vincent, Indianapolis, IN, USA.
  • Jin X; Department of Anatomy and Cell Biology, Indiana University/Purdue University, Indianapolis, IN, USA.
  • Ping X; Department of Anatomy and Cell Biology, Indiana University/Purdue University, Indianapolis, IN, USA.
  • Biggerstaff A; School of Biological Sciences, Centre for Biodiscovery, Victoria University of Wellington, Wellington, New Zealand.
  • Kivell BM; School of Biological Sciences, Centre for Biodiscovery, Victoria University of Wellington, Wellington, New Zealand.
  • Knutson DE; Department of Chemistry and Biochemistry, Milwaukee Institute of Drug Discovery, University of Wisconsin-Milwaukee, Milwaukee, WI, USA.
  • Sharmin D; Department of Chemistry and Biochemistry, Milwaukee Institute of Drug Discovery, University of Wisconsin-Milwaukee, Milwaukee, WI, USA.
  • Pandey KP; Department of Chemistry and Biochemistry, Milwaukee Institute of Drug Discovery, University of Wisconsin-Milwaukee, Milwaukee, WI, USA.
  • Mian MY; Department of Chemistry and Biochemistry, Milwaukee Institute of Drug Discovery, University of Wisconsin-Milwaukee, Milwaukee, WI, USA.
  • Cook JM; RespireRx Pharmaceuticals Inc., Glen Rock, NJ, USA; Department of Chemistry and Biochemistry, Milwaukee Institute of Drug Discovery, University of Wisconsin-Milwaukee, Milwaukee, WI, USA.
  • Cerne R; Laboratory of Antiepileptic Drug Discovery, Ascension St. Vincent, Indianapolis, IN, USA; RespireRx Pharmaceuticals Inc., Glen Rock, NJ, USA; Department of Anatomy and Cell Biology, Indiana University/Purdue University, Indianapolis, IN, USA; Faculty of Medicine, University of Ljubljana, Zaloska ces
Pharmacol Biochem Behav ; 213: 173321, 2022 02.
Article em En | MEDLINE | ID: mdl-35041859
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oxazóis / Receptores de GABA / GABAérgicos / Transtornos Mentais / Doenças do Sistema Nervoso Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oxazóis / Receptores de GABA / GABAérgicos / Transtornos Mentais / Doenças do Sistema Nervoso Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article